Inotiv (NOTVQ) Other Accumulated Expenses (2021 - 2022)

Inotiv's (NOTVQ) quarterly Other Accumulated Expenses came in at $3.1 million in Q2 2022, up 1850.63% on a QoQ basis from $160000.0 in Q1 2022.

Inotiv (NOTVQ) Other Accumulated Expenses (2021 - 2022) Analysis & Trends

Inotiv (NOTVQ) has 2 years of Other Accumulated Expenses data on file, last reported at $3.1 million in Q2 2022.

Quarterly Other Accumulated Expenses changed N/A year-over-year to $3.1 million in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $3.1 million (changed N/A YoY) and the FY2021 annual result came in at $366000.0, changed N/A from the prior year.
Other Accumulated Expenses rose to $3.1 million in Q2 2022, from $160000.0 in the prior quarter.
In the past five years, Other Accumulated Expenses ranged from a high of $8.1 million in Q4 2021 to a low of $160000.0 in Q1 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn
10	Inotiv	348,881.46	-14.83 Mn	111.99 Mn

Download Data